Investigation of Correlation between Expression of Glioma Diphtheria Toxin Receptor and Pathological Grade of Glioma

Expression of diphtheria toxin a chain gene in plants could inhibit their protein synthesis

白喉毒素A链基因在植物中的表达能抑制蛋白质合成

The nurse gave the patient an injection of penicillin.

护士给患者打了一针青霉素.

Reading the patient's file, Andrew observed the warning about Penicillin.

阅读病历时, 安德鲁看到了青霉素的记号.

Effects of orlistat on endothelium-independent vasodilation function in obese subjects with hypertension

奥利司他对肥胖高血压患者非内皮依赖性血管舒张功能的影响

Orlistat for adjutant treatment of fatty type 2 diabetes mellitus in 32 patients

奥利司他辅助治疗肥胖2型糖尿病32例

The serum free testosterone also decreased in the tested groups while the sex hormone binding globulin increased.

奥利司他组游离睾酮显著下降伴随性激素结合球蛋白明显上升；

Efficacy analysis of oseltamivir treatment of suspected influenza A H1N1 influenza

奥司他韦治疗疑似甲型H1N1流感的疗效分析

Structure Confirmation of Anti-influenza Drug Oseltamivir Phosphate

抗流感药物奥司他韦的结构确证

The curative effect of oseltamivir on borderline case of influenza

奥司他韦治疗流感疑似病例疗效观察

In test groups, both 1:5 complex lysostaphin interacted with virus for 30 minutes and oseltamivir treatment group were most effective, and there was no difference between these two groups ( P> 0.05).

溶葡萄球菌复合酶1：5稀释后与病毒作用30min和磷酸奥司他韦治疗组的抗病毒效果最显著，且两者间差别无统计学意义（P>0.05）。

Cases of oseltamivir-resistant viruses continue to be sporadic and infrequent, with no evidence that oseltamivir-resistant pandemic H1N1 viruses are circulating within communities or worldwide.

对奥司他韦具有耐药性的病毒仍是零星和罕见的，而且并无证据表明对奥司他韦具有耐药性的H1N1大流行性流感病毒正在社区或全球范围内传播。

Methods: 60 patients were divided into 2 groups randomly. Treatment group of 30 cases were given oseltamivir 2 mg/ kg, twice daily by mouth; control group of 30 cases were given ribavirin 10 mg/ ( kg · d) by vein.

方法：60例流感疑似病例随机分为2组，治疗组30例口服奥司他韦2mg/（kg.次），2次/d，对照组30例静脉滴注利巴韦林10mg/（kg.d），疗程均为5d。

Except for immunocompromised patients, those infected with an oseltamivir-resistant pandemic H1N1 virus have experienced typical uncomplicated influenza symptoms.

除了免疫功能低下的患者外，受到对奥司他韦具有耐药性的H1N1大流行性流感病毒感染者显示典型的简单流感症状。

Objective: To evaluate the efficacy of oseltamivir in the treatment of early influenza.

目的：观察磷酸奥司他韦治疗早期流感的疗效。

Laboratory testing on these swine influenza A ( H1N1) viruses so far indicate that they are susceptible ( sensitive) to oseltamivir and zanamivir.

目前实验室检测证实这些猪流感病毒A（H1N1）对奥司他韦和扎那米韦敏感。

In intensive care unit ( ICU), oseltamivir, corticosteroid treatment and supportive treatment were given, finally 2 patients died. Conclusion: Influenza A H1N1 should early diagnosis and early treatment.

重症监护病房监护治疗下给予奥司他韦抗病毒治疗、糖皮质激素治疗及对症支持治疗，2例患者最终抢救无效死亡。结论：甲型H1N1流感需早期诊断、早期治疗。

WHO received the first report of an oseltamivir-resistant pandemic virus in July.

世卫组织在今年7月首次收到关于大流行性流感病毒对奥司他韦具有耐药性的报告。

All of these viruses show the same H275Y mutation that confers resistance to the antiviral oseltamivir, but not to the antiviral zanamivir.

所有这些病毒都呈现出同样的H275Y变异，对奥司他韦抗病毒药物产生了耐药性，但却并不对扎那米韦抗病毒药物具有耐药性。

The control groups were treated with oral Oseltamivir Capsules, 75mg/ time, twice a day.

对照组均予口服磷酸奥司他韦胶囊，75mg／次，一天两次，观察其临床疗效。

Four were isolated from samples from patients receiving oseltamivir treatment.

4个耐药性病毒来自接受奥司他韦治疗的患者样本。